Clinical trial
A Study of LY2189102 in Patients With Type 2 Diabetes
NCT00942188
Study timeline
Study start (unknown)2009-06-01Date precision: month
Registry last updated2019-09-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1San AntonioTexas, United States1Washington D.C.District of Columbia, United States1Salt Lake CityUtah, United States1RichmondVirginia, United States1Walnut CreekCalifornia, United States1AnaheimCalifornia, United States1MobileAlabama, United States1BoiseIdaho, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00942188 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.